RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Merck KGaA, Darmstadt, Germany
M

Merck KGaA, Darmstadt, Germany portfolio

Merck KGaA, Darmstadt, Germany has 1 portfolio company on record at Recent Funding. Its most recent investment on record is IDRx's $120M Series B+ round in August 2024, alongside Rock Springs Capital, RA Capital Management, Nick Lydon and 6 others. That company is in Health and bio.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $120M.
Latest deal: IDRx · Aug 8, 2024.

What Merck KGaA, Darmstadt, Germany invests in

How Merck KGaA, Darmstadt, Germany invests

StageDealsCapital in rounds
Series B+ 1 100%$120M

Share is of the 1 round on Recent Funding that name Merck KGaA, Darmstadt, Germany. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Merck KGaA, Darmstadt, Germany portfolio companies

CompanyRound with Merck KGaA, Darmstadt, GermanyTotal raisedLatest raise
IIDRx
Health and bio
Series B+ · $120M$242MAug 8, 2024
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Merck KGaA, Darmstadt, Germany, which is a subset of its real portfolio. API: /api/v1/investors/merck-kgaa-darmstadt-germany (get a free API key). More: the most active VC firms and new venture capital funds.